Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Pediatric cerebrovascular disease

소아 뇌혈관질환

  • Phi, Ji Hoon (Division of Pediatric Neurosurgery, Seoul National University Children's Hospital) ;
  • Wang, Kyu-Chang (Division of Pediatric Neurosurgery, Seoul National University Children's Hospital) ;
  • Cho, Byung-Kyu (Division of Pediatric Neurosurgery, Seoul National University Children's Hospital) ;
  • Kim, Seung-Ki (Division of Pediatric Neurosurgery, Seoul National University Children's Hospital)
  • 피지훈 (서울대학교 어린이병원 소아청소년신경외과) ;
  • 왕규창 (서울대학교 어린이병원 소아청소년신경외과) ;
  • 조병규 (서울대학교 어린이병원 소아청소년신경외과) ;
  • 김승기 (서울대학교 어린이병원 소아청소년신경외과)
  • Received : 2008.11.01
  • Accepted : 2008.11.14
  • Published : 2008.12.15
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, accumulated clinical experience and advanced neuroradiological techniques have led to a better understanding of pediatric cerebrovascular disease (CVD), which was once considered rare. Approximately 10% of pediatric neurosurgical patients have CVD; therefore, it is no longer uncommon to pediatricians and pediatric neurosurgeons. Furthermore, children with CVD tend to recover better than adults after stroke because the immature brain is more plastic than the mature one. Therefore, active treatment often proves more rewarding in pediatric medicine than in adult medicine.

Keywords

Acknowledgement

Supported by : Ministry for Health, Welfare and Family Affairs, Seoul National University Children's Hospital

References

  1. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol 2008;7:1056-66 https://doi.org/10.1016/S1474-4422(08)70240-0
  2. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 2008;39:42-7 https://doi.org/10.1161/STROKEAHA.107.490714
  3. Han DH, Kwon OK, Byun BJ, Choi BY, Choi CW, Choi JU, et al. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 2000;142:1263-73; discussion 73-4 https://doi.org/10.1007/s007010070024
  4. Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK. Familial occurrence of moyamoya disease: a clinical study. Childs Nerv Syst 2006;22:1143-8 https://doi.org/10.1007/s00381-006-0089-4
  5. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999;64:533-7 https://doi.org/10.1086/302243
  6. Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, Fukui M, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 2004;49:278-81 https://doi.org/10.1007/s10038-004-0143-6
  7. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000;31:930-5 https://doi.org/10.1161/01.STR.31.4.930
  8. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004;100:142-9
  9. Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK. Headache in pediatric moyamoya disease: review of 204 consecutive cases. J Neurosurg 2005;103:439-42 https://doi.org/10.3171/jns.2005.103.3.0439
  10. Kim HY, Chung CS, Lee J, Han DH, Lee KH. Hyperventilation- induced limb shaking TIA in Moyamoya disease. Neurology 2003;60:137-139 https://doi.org/10.1212/01.WNL.0000039067.80149.03
  11. Im SH, Oh CW, Kwon OK, Cho BK, Chung YS, Han DH. Involuntary movement induced by cerebral ischemia: pathogenesis and surgical outcome. J Neurosurg 2004;100:877-82 https://doi.org/10.3171/jns.2004.100.5.0877
  12. Seol HJ, Wang KC, Kim SK, Lee CS, Lee DS, Kim IO, et al. Unilateral (probable) moyamoya disease: long-term follow-up of seven cases. Childs Nerv Syst 2006;22:145-50 https://doi.org/10.1007/s00381-005-1234-1
  13. Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 2004;54:840-4; discussion 44-6 https://doi.org/10.1227/01.NEU.0000114140.41509.14
  14. Kim SK, Wang KC, Kim IO, Lee DS, Cho BK. Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo (periosteal) synangiosis in pediatric moyamoya disease. Neurosurgery 2002;50:88-96 https://doi.org/10.1097/00006123-200201000-00016
  15. Uranishi R, Baev NI, Ng PY, Kim JH, Awad IA. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery 2001;48:359-67 https://doi.org/10.1097/00006123-200102000-00024
  16. Kader A, Goodrich JT, Sonstein WJ, Stein BM, Carmel PW, Michelsen WJ. Recurrent cerebral arteriovenous malformations after negative postoperative angiograms. J Neurosurg 1996;85:14-8 https://doi.org/10.3171/jns.1996.85.1.0014
  17. Stapf C, Mohr JP, Pile-Spellman J, Sciacca RR, Hartmann A, Schumacher HC, et al. Concurrent arterial aneurysms in brain arteriovenous malformations with haemorrhagic presentation. J Neurol Neurosurg Psychiatry 2002;73:294-8 https://doi.org/10.1136/jnnp.73.3.294
  18. Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet 2002;359:863-73 https://doi.org/10.1016/S0140-6736(02)07946-1
  19. Humphreys RP. Arteriovenous malformations. In: Alpright AL, Pollack IF, Adelson PD, editors. Principles and Practice of Pediatric Neurosurgery. 2nd ed. New York: Thieme Co, 2008:983-94
  20. Wikholm G, Lundqvist C, Svendsen P. Embolization of cerebral arteriovenous malformations: Part I--Technique, morphology, and complications. Neurosurgery 1996;39:448-57 https://doi.org/10.1097/00006123-199609000-00004
  21. Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig- Rigamonti K, Knight JT, et al. Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 1988;319:343-7 https://doi.org/10.1056/NEJM198808113190605
  22. Gunel M, Laurans MS, Shin D, DiLuna ML, Voorhees J, Choate K, et al. KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci U S A 2002;99:10677-82 https://doi.org/10.1073/pnas.122354499
  23. Laurans MS, DiLuna ML, Shin D, Niazi F, Voorhees JR, Nelson-Williams C, et al. Mutational analysis of 206 families with cavernous malformations. J Neurosurg 2003;99:38-43 https://doi.org/10.3171/jns.2003.99.1.0038
  24. Nimjee SM, Powers CJ, Bulsara KR. Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy. Neurosurg Focus 2006;21:e4
  25. Aiba T, Tanaka R, Koike T, Kameyama S, Takeda N, Komata T. Natural history of intracranial cavernous malformations. J Neurosurg 1995;83:56-9 https://doi.org/10.3171/jns.1995.83.1.0056
  26. Pollock BE, Garces YI, Stafford SL, Foote RL, Schomberg PJ, Link MJ. Stereotactic radiosurgery for cavernous malformations. J Neurosurg 2000;93:987-91 https://doi.org/10.3171/jns.2000.93.6.0987
  27. Awad I, Jabbour P. Cerebral cavernous malformations and epilepsy. Neurosurg Focus 2006;21:e7
  28. Patel AN, Richardson AE. Ruptured intracranial aneurysms in the first two decades of life. A study of 58 patients. J Neurosurg 1971;35:571-6 https://doi.org/10.3171/jns.1971.35.5.0571
  29. Vilela P, Goulao A. Paediatric dissecting posterior cerebral aneurysms: report of two cases and review of the literature. Neuroradiology 2006;48:541-8 https://doi.org/10.1007/s00234-006-0086-z
  30. Steiger HJ, Fritschi J, Seiler RW. Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine. Acta Neurochir (Wien) 1994;127:21-6 https://doi.org/10.1007/BF01808541

Cited by

  1. A Case of Moyamoya Disease Initially Presenting as Anterior Ischemic Optic Neuropathy vol.52, pp.7, 2011, https://doi.org/10.3341/jkos.2011.52.7.887